https://www.nytimes.com/2021/06/16/us/emergent-biosolutions-covid-vaccine.html?action=click&module=Top%20Stories&pgtype=Homepage
since your recommendation, it has lost half its value.
Recent EBS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2024 09:18:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 09:04:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 09:04:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 10:16:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/12/2024 09:26:14 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/12/2024 09:06:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 03:34:56 PM
- Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa • GlobeNewswire Inc. • 11/06/2024 09:49:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:12:02 PM
- Emergent BioSolutions Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/06/2024 09:05:00 PM
- Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development • GlobeNewswire Inc. • 11/04/2024 12:30:00 PM
- Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 • GlobeNewswire Inc. • 10/23/2024 11:30:55 AM
- Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic • GlobeNewswire Inc. • 10/08/2024 09:32:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 11:29:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 12:11:30 PM
- Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility • GlobeNewswire Inc. • 10/02/2024 11:30:00 AM
- Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts • GlobeNewswire Inc. • 09/26/2024 12:05:00 PM
- Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts • GlobeNewswire Inc. • 09/25/2024 11:07:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:12:31 PM
- Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation • GlobeNewswire Inc. • 09/13/2024 10:45:00 AM
- Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola • GlobeNewswire Inc. • 09/12/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 11:47:30 AM
- Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile • GlobeNewswire Inc. • 09/03/2024 11:08:45 AM
- Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness • GlobeNewswire Inc. • 08/30/2024 12:16:09 PM
- Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions • GlobeNewswire Inc. • 08/29/2024 10:53:02 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM